-transparent.png){kind=logo}
The in vitro activities of three newly developed quinolone drugs (T-3262, NY-198, and fleroxacin [AM-833; RO 23-6240]) against 10 strains of clinically isolated Chlamydia trachomatis were assessed and compared with those of other quinolones and minocycline. T-3262 (MIC for 90% of isolates tested, 0.1 microgram/ml) was the most active of the quinolones. The NY-198 and fleroxacin MICs for 90% of isolates were 3.13 and 62.5 micrograms/ml, respectively.
Related Publications
H Maeda, and
A Fujii, and
K Nakata, and
S Arakawa, and
S Kamidono
January 1987,
Drugs under experimental and clinical research,
H Maeda, and
A Fujii, and
K Nakata, and
S Arakawa, and
S Kamidono
June 1987,
Chemioterapia : international journal of the Mediterranean Society of Chemotherapy,
H Maeda, and
A Fujii, and
K Nakata, and
S Arakawa, and
S Kamidono
April 1988,
The Journal of antimicrobial chemotherapy,
H Maeda, and
A Fujii, and
K Nakata, and
S Arakawa, and
S Kamidono
February 1988,
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
H Maeda, and
A Fujii, and
K Nakata, and
S Arakawa, and
S Kamidono
April 1987,
Diagnostic microbiology and infectious disease,
H Maeda, and
A Fujii, and
K Nakata, and
S Arakawa, and
S Kamidono
January 1988,
Chemotherapy,
H Maeda, and
A Fujii, and
K Nakata, and
S Arakawa, and
S Kamidono
August 1987,
European journal of clinical microbiology,
H Maeda, and
A Fujii, and
K Nakata, and
S Arakawa, and
S Kamidono
August 1987,
European journal of clinical microbiology,
H Maeda, and
A Fujii, and
K Nakata, and
S Arakawa, and
S Kamidono
July 1987,
Antimicrobial agents and chemotherapy,
H Maeda, and
A Fujii, and
K Nakata, and
S Arakawa, and
S Kamidono
May 1987,
Diagnostic microbiology and infectious disease,
